222 related articles for article (PubMed ID: 11412128)
1. Slow-binding inhibition of human prostaglandin endoperoxide synthase-2 with darbufelone, an isoform-selective antiinflammatory di-tert-butyl phenol.
Johnson AR; Marletta MA; Dyer RD
Biochemistry; 2001 Jun; 40(25):7736-45. PubMed ID: 11412128
[TBL] [Abstract][Full Text] [Related]
2. Investigation of the binding of isoform-selective inhibitors to prostaglandin endoperoxide synthases using fluorescence spectroscopy.
Lanzo CA; Beechem JM; Talley J; Marnett LJ
Biochemistry; 1998 Jan; 37(1):217-26. PubMed ID: 9425042
[TBL] [Abstract][Full Text] [Related]
3. The interaction of arginine 106 of human prostaglandin G/H synthase-2 with inhibitors is not a universal component of inhibition mediated by nonsteroidal anti-inflammatory drugs.
Greig GM; Francis DA; Falgueyret JP; Ouellet M; Percival MD; Roy P; Bayly C; Mancini JA; O'Neill GP
Mol Pharmacol; 1997 Nov; 52(5):829-38. PubMed ID: 9351974
[TBL] [Abstract][Full Text] [Related]
4. Role of Val509 in time-dependent inhibition of human prostaglandin H synthase-2 cyclooxygenase activity by isoform-selective agents.
Guo Q; Wang LH; Ruan KH; Kulmacz RJ
J Biol Chem; 1996 Aug; 271(32):19134-9. PubMed ID: 8702589
[TBL] [Abstract][Full Text] [Related]
5. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC
Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894
[TBL] [Abstract][Full Text] [Related]
6. On the interaction of specific prostaglandin H synthase-2 inhibitors with prostaglandin H synthase-1.
Burde T; Rimon G
Eur J Pharmacol; 2002 Oct; 453(2-3):167-73. PubMed ID: 12398900
[TBL] [Abstract][Full Text] [Related]
7. The role of arginine 120 of human prostaglandin endoperoxide H synthase-2 in the interaction with fatty acid substrates and inhibitors.
Rieke CJ; Mulichak AM; Garavito RM; Smith WL
J Biol Chem; 1999 Jun; 274(24):17109-14. PubMed ID: 10358065
[TBL] [Abstract][Full Text] [Related]
8. Purification, characterization and selective inhibition of human prostaglandin G/H synthase 1 and 2 expressed in the baculovirus system.
Barnett J; Chow J; Ives D; Chiou M; Mackenzie R; Osen E; Nguyen B; Tsing S; Bach C; Freire J
Biochim Biophys Acta; 1994 Nov; 1209(1):130-9. PubMed ID: 7947975
[TBL] [Abstract][Full Text] [Related]
9. Kinetics of the interaction of nonsteroidal antiinflammatory drugs with prostaglandin endoperoxide synthase-1 studied by limited proteolysis.
Kalgutkar AS; Crews BC; Marnett LJ
Biochemistry; 1996 Jul; 35(28):9076-82. PubMed ID: 8703911
[TBL] [Abstract][Full Text] [Related]
10. Determinants of the cellular specificity of acetaminophen as an inhibitor of prostaglandin H(2) synthases.
Boutaud O; Aronoff DM; Richardson JH; Marnett LJ; Oates JA
Proc Natl Acad Sci U S A; 2002 May; 99(10):7130-5. PubMed ID: 12011469
[TBL] [Abstract][Full Text] [Related]
11. Differential inhibition of murine prostaglandin synthase-1 and -2 by nonsteroidal anti-inflammatory drugs using exogenous and endogenous sources of arachidonic acid.
Chulada PC; Langenbach R
J Pharmacol Exp Ther; 1997 Feb; 280(2):606-13. PubMed ID: 9023270
[TBL] [Abstract][Full Text] [Related]
12. Pharmacology of prostaglandin endoperoxide synthase isozymes-1 and -2.
Smith WL; Meade EA; DeWitt DL
Ann N Y Acad Sci; 1994 Apr; 714():136-42. PubMed ID: 8017762
[TBL] [Abstract][Full Text] [Related]
13. Effects of novel anti-inflammatory compounds on healing of acetic acid-induced gastric ulcer in rats.
Lesch CA; Gilbertsen RB; Song Y; Dyer RD; Schrier D; Kraus ER; Sanchez B; Guglietta A
J Pharmacol Exp Ther; 1998 Oct; 287(1):301-6. PubMed ID: 9765350
[TBL] [Abstract][Full Text] [Related]
14. Structure-based QSAR study on differential inhibition of human prostaglandin endoperoxide H synthase-2 (COX-2) by nonsteroidal anti-inflammatory drugs.
Pouplana R; Lozano JJ; Pérez C; Ruiz J
J Comput Aided Mol Des; 2002 Oct; 16(10):683-709. PubMed ID: 12650588
[TBL] [Abstract][Full Text] [Related]
15. Comparison of hydroperoxide initiator requirements for the cyclooxygenase activities of prostaglandin H synthase-1 and -2.
Kulmacz RJ; Wang LH
J Biol Chem; 1995 Oct; 270(41):24019-23. PubMed ID: 7592599
[TBL] [Abstract][Full Text] [Related]
16. PGH synthase isoenzyme selectivity: the potential for safer nonsteroidal antiinflammatory drugs.
DeWitt DL; Meade EA; Smith WL
Am J Med; 1993 Aug; 95(2A):40S-44S. PubMed ID: 8357002
[TBL] [Abstract][Full Text] [Related]
17. Role of Asn-382 and Thr-383 in activation and inactivation of human prostaglandin H synthase cyclooxygenase catalysis.
Bambai B; Rogge CE; Stec B; Kulmacz RJ
J Biol Chem; 2004 Feb; 279(6):4084-92. PubMed ID: 14625295
[TBL] [Abstract][Full Text] [Related]
18. Conversion of prostaglandin G/H synthase-1 into an enzyme sensitive to PGHS-2-selective inhibitors by a double His513 --> Arg and Ile523 --> val mutation.
Wong E; Bayly C; Waterman HL; Riendeau D; Mancini JA
J Biol Chem; 1997 Apr; 272(14):9280-6. PubMed ID: 9083063
[TBL] [Abstract][Full Text] [Related]
19. Characterization of autocrine inducible prostaglandin H synthase-2 (PGHS-2) in human osteosarcoma cells.
Wong E; DeLuca C; Boily C; Charleson S; Cromlish W; Denis D; Kargman S; Kennedy BP; Ouellet M; Skorey K; O'Neill GP; Vickers PJ; Riendeau D
Inflamm Res; 1997 Feb; 46(2):51-9. PubMed ID: 9085144
[TBL] [Abstract][Full Text] [Related]
20. Purification and characterization of the human recombinant histidine-tagged prostaglandin endoperoxide H synthases-1 and -2.
Smith T; Leipprandt J; DeWitt D
Arch Biochem Biophys; 2000 Mar; 375(1):195-200. PubMed ID: 10683267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
